Morphosys Ag ADR (MOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MOR | ACAD | MLTX | ||
| Company | Morphosys Ag ADR | Acadia Pharmaceutica | Moonlake Immunotherapeutics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 17.55 | 16.90 | 42.82 | ||
| High | 17.61 | 17.57 | 43.17 | ||
| Low | 17.04 | 16.85 | 40.97 | ||
| Last | 17.36 | 17.10 | 41.77 | ||
| Change | -0.68 | +0.39 | -0.72 | ||
| % Change | -3.77% | +2.33% | -1.69% | ||
| Volume | 4,541,600 | 1,887,700 | 253,200 | ||
| 20-Day Average Volume | 567,320 | 1,437,200 | 358,335 | ||
| Previous Close | 18.04 | 16.71 | 42.49 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 18.02 | 17.32 | 44.17 | ||
| 20-Day Raw Stochastic | 27.59% | 38.06% | 14.16% | ||
| 20-Day Relative Strength | 46.11% | 36.66% | 37.66% | ||
| Weighted Alpha | +61.15 | -44.82 | -10.03 | ||
| Today's Opinion | 64% Buy | 100% Sell | 96% Sell | ||
| Previous Opinion | 88% Buy | 100% Sell | 88% Sell | ||
| Last Month's Opinion | 100% Buy | 100% Sell | 40% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.34% since 04/22/24 | +0.65% since 04/22/24 | +1.83% since 04/22/24 | ||
| Low | 17.04 on 04/29/24 | 16.16 on 04/25/24 | 40.97 on 04/29/24 | ||
| High | 18.15 on 04/25/24 | 17.57 on 04/29/24 | 43.60 on 04/24/24 | ||
| 1-Month | |||||
| %Chg | -4.30% since 03/28/24 | -7.52% since 03/28/24 | -16.84% since 03/28/24 | ||
| Low | 17.04 on 04/29/24 | 16.16 on 04/25/24 | 40.68 on 04/19/24 | ||
| High | 18.20 on 04/09/24 | 18.63 on 04/04/24 | 50.28 on 04/01/24 | ||
| 3-Month | |||||
| %Chg | +58.97% since 01/29/24 | -37.91% since 01/29/24 | -28.19% since 01/29/24 | ||
| Low | 10.39 on 01/31/24 | 16.16 on 04/25/24 | 40.68 on 04/19/24 | ||
| High | 18.31 on 03/12/24 | 27.94 on 01/30/24 | 64.98 on 02/12/24 | ||
| 6-Month | |||||
| %Chg | +127.82% since 10/27/23 | -21.42% since 10/27/23 | -16.41% since 10/27/23 | ||
| Low | 4.18 on 11/22/23 | 16.16 on 04/25/24 | 35.11 on 11/06/23 | ||
| High | 18.31 on 03/12/24 | 32.59 on 12/22/23 | 64.98 on 02/12/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,717,203 | 2,753,340 | 2,714,559 | ||
| Shares Outstanding, K | 150,621 | 164,772 | 63,887 | ||
| Annual Sales | 257,890,000 | 726,440,000 | 0 | ||
| Annual Net Income | -205,350,000 | -61,290,000 | -36,010,000 | ||
| Last Quarter Sales | 63,610,000 | 231,040,000 | 0 | ||
| Last Quarter Net Income | 53,170,000 | 45,800,000 | -5,330,000 | ||
| 60-Month Beta | 1.17 | 0.37 | 1.20 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.33 on 03/13/24 | 0.28 on 02/27/24 | -0.12 on 02/29/24 | ||
| Latest Earnings Date | 05/01/24 | 05/08/24 | 05/10/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||